Shilpa Medicare Limited

Shilpa Medicare Ltd is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a robust presence in therapeutic areas such as oncology, anti-virals, and contract research and manufacturing services (CRAMS). Building on advanced capabilities in chemical synthesis, complex generics, and sterile injectables, Shilpa Medicare serves a global clientele that includes regulatory markets across the US, Europe, and other emerging economies.

Research and development is central to the company’s strategy, with dedicated facilities focused on process innovation, product diversification, and regulatory compliance. Shilpa Medicare's portfolio encompasses APIs, formulations, novel drug delivery systems, and specialized offerings like high-potency oncology drugs and biosimilars. The company adheres to international quality standards, supported by approvals from authorities including USFDA, EU GMP, and WHO. Its manufacturing facilities are located predominantly in southern India, with a growing export orientation.